Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07465705

Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)

A Phase III, International, Multicenter, Randomized, Parallel-group, Endoscopist-blinded Non-inferiority Study of the Efficacy, Safety and Patient Acceptance of Mannitol Versus Plenvu® in Bowel Preparation for Elective Colonoscopy. CLEARWAY

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
412 (estimated)
Sponsor
NTC srl · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study to test the non-inferiority of bowel cleansing with 100 g Mannitol against standard Plenvu® same-day dosing regimen. The 50% of the subjects will receive Mannitol, while the remaining part will receive Plenvu®.

Detailed description

Not provided

Conditions

Interventions

TypeNameDescription
DRUG100g of MannitolParticipants should self administer the preparation within 45 minutes, dissolving 100g of powder in 1L of water
DRUG1L PEG-AscSelf administration of the same day preparation according to the on lable instruction for use. The first dose consists in dissolving Dose 1 in 500ml of water, followed by another 500ml of water, all within 1 hour. After a 1 hour wait from the end of the first dose, the participant should self administer the Dose 2 consisting in dissolving one sachetA and one sachetB in 500ml of water, followed by another 500ml of water; all within 1 hour.

Timeline

Start date
2025-09-02
Primary completion
2026-03-31
Completion
2026-06-30
First posted
2026-03-12
Last updated
2026-03-13

Locations

18 sites across 5 countries: Belgium, Italy, Poland, Spain, Sweden

Source: ClinicalTrials.gov record NCT07465705. Inclusion in this directory is not an endorsement.